Home

Dana G Jr. Mead

CIK 1222358 · last filed 2026-06-09

Dana G Jr. Mead is a corporate insider who has filed 45 SEC Form 4 insider transactions across 6 companies since 2014. The most recent filing, for LUNG, was dated Jun 9, 2026. Across all open-market trades the lifetime net is +$1.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.71M

Companies

6

Total Filings

45

Lifetime Open-Market Net

$1.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LUNG Director 143,790 $1.25 $179.7K $500.0K 8 2026-06-09
MOBI Director 7,000 $10.72 $75.0K $105.0K 1 2026-05-11
INSP Director 26,213 $51.97 $1.36M $320.0K 9 2026-05-04
Inari Medical, Inc. (NARI) Delisted Director 0 $79.97 $0 $0 6 2025-02-19
Intersect ENT, Inc. (XENT) Delisted Director 1,751,828 $28.24 $49.47M $99.9K 14 2022-05-16
TDOC Director 10,202 $9.36 $95.5K $106.5K 7 2016-08-10

Recent Filings

45 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-09 LUNG Grant (A) +40,000 $0 EDGAR
2026-05-11 MOBI Mixed +7,000 $105.0K EDGAR
2026-05-04 INSP Grant (A) +3,562 $0 EDGAR
2025-06-04 LUNG Grant (A) +37,153 $0 EDGAR
2025-05-05 INSP Grant (A) +1,266 $0 EDGAR
2025-02-19 Inari Medical, Inc. (NARI) Delisted U −11,148 $0 EDGAR
2024-06-05 LUNG Grant (A) +15,216 $0 EDGAR
2024-05-31 Inari Medical, Inc. (NARI) Delisted Grant (A) +4,126 $175.0K EDGAR
2024-05-06 INSP Grant (A) +716 $0 EDGAR
2024-04-26 Inari Medical, Inc. (NARI) Delisted Grant (A) +4,126 $175.0K EDGAR
Showing 1–10 of 45
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.